PetIQ Competitors

Summary

PETQDelisted Stock

USD 30.98 0.00 0.00%

PetIQ Inc competes with Prestige Brand, Collegium Pharmaceutical, Regencell Bioscience, Pacira BioSciences,, and Phibro Animal; as well as few others. The company conducts business under Health Care Providers & Services sector and is part of Health Care industry. Analyzing PetIQ competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of PetIQ to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of PetIQ competition on your existing holdings.

Specify up to 10 symbols:

Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of PetIQ's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.

Hype

Prediction

Low	Estimated	High
30.92	30.98	31.04

Details

Intrinsic

Valuation

Low	Real	High
24.06	24.12	34.08

Details

PetIQ Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between PetIQ and its competitors represents the degree of relationship between the price movements of corresponding delisted stocks. A correlation of about +1.0 implies that the price of PetIQ and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of PetIQ Inc does not affect the price movement of the other competitor.

	PBH	EGRX	COLL	SSIC	RGC	PCRX	PAHC	RDY	ZTS	EBS
PBH		-0.61	-0.89	0.88	0.19	0.59	0.37	-0.85	-0.7	0.24	PBH
EGRX	-0.61		0.77	-0.62	-0.19	-0.7	0.02	0.42	0.84	-0.03	EGRX
COLL	-0.89	0.77		-0.85	-0.2	-0.67	-0.2	0.77	0.88	-0.06	COLL
SSIC	0.88	-0.62	-0.85		0.31	0.55	0.22	-0.77	-0.79	0.22	SSIC
RGC	0.19	-0.19	-0.2	0.31		-0.2	0.34	-0.39	-0.14	0.25	RGC
PCRX	0.59	-0.7	-0.67	0.55	-0.2		-0.01	-0.37	-0.7	0.06	PCRX
PAHC	0.37	0.02	-0.2	0.22	0.34	-0.01		-0.38	0.06	0.52	PAHC
RDY	-0.85	0.42	0.77	-0.77	-0.39	-0.37	-0.38		0.56	-0.24	RDY
ZTS	-0.7	0.84	0.88	-0.79	-0.14	-0.7	0.06	0.56		-0.08	ZTS
EBS	0.24	-0.03	-0.06	0.22	0.25	0.06	0.52	-0.24	-0.08		EBS
	PBH	EGRX	COLL	SSIC	RGC	PCRX	PAHC	RDY	ZTS	EBS

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

High positive correlations

SSIC	+ 0.88	PBH
ZTS	+ 0.88	COLL
ZTS	+ 0.84	EGRX
COLL	+ 0.77	EGRX
RDY	+ 0.77	COLL
PCRX	+ 0.59	PBH

High negative correlations

COLL	- 0.89	PBH
SSIC	- 0.85	COLL
RDY	- 0.85	PBH
ZTS	- 0.79	SSIC
RDY	- 0.77	SSIC
ZTS	- 0.7	PCRX

Risk-Adjusted Indicators

There is a big difference between PetIQ Stock performing well and PetIQ Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze PetIQ's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
PBH	0.88	0.15	0.10	0.49	1.08	(0.88)	1.72	(1.89)	5.83
EGRX	3.94	(1.21)	0.00	(2.82)	0.00	0.00	9.24	(8.24)	53.71
COLL	1.89	(0.36)	0.00	13.55	0.00	0.00	2.86	(4.47)	12.29
SSIC	1.02	0.21	0.17	(8.70)	0.80	(1.39)	3.36	(1.54)	8.15
RGC	5.73	0.10	0.02	0.22	5.99	(7.13)	19.02	(10.93)	43.32
PCRX	2.07	0.55	0.23	22.11	1.92	(2.36)	4.58	(3.23)	17.68
PAHC	1.66	(0.06)	0.00	(0.24)	0.00	0.00	3.42	(3.00)	12.19
RDY	1.07	(0.01)	(0.02)	(0.03)	1.29	(1.18)	1.90	(1.95)	6.89
ZTS	1.02	(0.23)	0.00	(2.71)	0.00	0.00	1.74	(2.80)	5.70
EBS	4.26	0.66	0.12	1.23	4.91	(4.55)	11.40	(8.45)	39.28

Unable to evaluate fundamental data of [PBH, EGRX, COLL, SSIC, RGC, PCRX, PAHC, RDY, ZTS, EBS, BHC, NBIX, ANIP, DCPH, EVO, SUPN] at this time. Please try again later

All Fundamental Data

PetIQ Competitive Analysis

The better you understand PetIQ competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, PetIQ's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across PetIQ's competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	PETQ	PBH	EGRX	COLL	SSIC	RGC	PCRX	PAHC	RDY	ZTS
	0.00 30.98 PetIQ	0.98 78.45 Prestige	1.02 1.99 Eagle	1.29 29.11 Collegium	0.62 12.80 Silver	0.61 4.90 Regencell	0.81 19.65 Pacira	2.91 21.05 Phibro	1.86 15.86 RDY	0.56 164.60 Zoetis
Market Volatility (90 Days Market Risk)	Very steady	Very steady	Abnormally volatile	Very steady	Not too volatile	Very risky	Very steady	Not too volatile	Very steady	Very steady
Market Performance (90 Days Performance)	Excellent	OK	Very Weak	Very Weak	Solid	Weak	Good	Very Weak	Very Weak	Very Weak
Odds of Financial Distress (Probability Of Bankruptcy)	Dangerous	Very Low	Dangerous	Very Low	Dangerous	About Average	Below Average	Low	Very Low	Low
Current Valuation (Equity Enterprise Value)	Over Valued	Fairly Valued	Over Valued	Under Valued	Over Valued	Over Valued	Under Valued	Over Valued	Under Valued	Under Valued
Buy or Sell Advice (Average Analysts Consensus)	Not Available	Buy	Not Available	Buy	Not Available	Not Available	Buy	Hold	Buy	Strong Buy
Trade Advice (90 Days Macroaxis Advice)	Not Rated	Strong Buy	Not Rated	Buy	Not Rated	Strong Hold	Strong Hold	Strong Buy	Buy	Buy
Current Ratio	2.88	2.09	1.78	0.99	111.63	13.94	3.95	2.97	1.98	2.18
Net Asset	868.23 M	3.32 B	406.16 M	1.14 B	88.58 M	8.44 M	1.57 B	982.18 M	387.52 B	14.29 B
Profit Margin	0.0116	0.19	0.0464	0.15	0.45	N/A	-0.13	0.0166	0.18	0.27
EBITDA	104.59 M	373.86 M	65.48 M	308.33 M	7.34 M	(3.62 M)	157.58 M	69.06 M	88.42 B	3.69 B
Operating Margin	0.0863	0.3	0.16	0.35	0.67	N/A	0.13	0.0811	0.23	0.39
Current Valuation	1.3 B	4.89 B	82.05 M	1.69 B	32.12 M	55.89 M	1.1 B	1.27 B	13.26 B	79.31 B
Price To Book	3.56	2.24	0.1	4.01	0.78	7.76	1.21	3.3	3.7	14.19
Retained Earnings	(160.6 M)	1.34 B	111.5 M	(233.19 M)	449.27 K	(21.62 M)	(106.8 M)	243.89 M	265.26 B	10.29 B
Current Asset	68.05 M	249.01 M	119.05 M	96.88 M	N/A	438.2 M	252.58 M	342.83 M	1.81 B	3.83 B
Five Year Return	N/A	N/A	N/A	N/A	N/A	4.37	N/A	1.85	0.72	0.55
Beta	1.74	0.47	0.52	0.95	0.28	-0.6	0.82	0.51	0.33	0.9
Number Of Employees	1.12 K	570	134	197	5	12	711	1.94 K	27.05 K	14.1 K
Shares Outstanding	29.67 M	49.41 M	12.96 M	32.25 M	6.21 M	13.01 M	46.17 M	20.34 M	833.08 M	451.16 M
Cash Flow From Operations	61.89 M	248.93 M	30.8 M	274.75 M	7.98 M	(4 M)	154.65 M	87.59 M	45.43 B	2.35 B
Annual Yield	N/A	N/A	N/A	N/A	0.094	N/A	N/A	0.0228	0.0062	0.0122
Total Debt	468.3 M	1.14 B	62.47 M	674.28 M	3.01 M	85.74 K	586.04 M	525.46 M	20.02 B	6.75 B
Return On Equity	0.0552	0.13	0.0488	0.43	0.0641	-0.43	-0.11	0.0655	0.19	0.47
Return On Asset	0.0486	0.0612	0.0663	0.0968	0.0562	-0.28	0.0417	0.0526	0.1	0.15
Number Of Shares Shorted	1.02 M	2.53 M	350.53 K	5.99 M	9.78 K	14.5 K	4.75 M	770.81 K	11.04 M	6.26 M
Book Value Per Share	8.71	35.03	19.25	7.27	13.56	0.63	16.24	6.38	366.54	11.59
Current Liabilities	11.3 M	106.68 M	35.45 M	8.43 M	N/A	551.3 M	149.79 M	108.78 M	976 M	1.78 B
Total Asset	868.23 M	3.32 B	406.16 M	1.14 B	88.58 M	8.44 M	1.57 B	982.18 M	387.52 B	14.29 B
Debt To Equity	1.81	0.95	0.23	3.82	N/A	0.069	1.1	1.79	0.12	1.48
Short Ratio	1.58	9.13	3.91	12.65	4.63	0.23	6.18	4.77	10.84	2.58
Target Price	30.5	85.29	17.0	42.25	8.8	N/A	18.13	19.4	15.28	213.01
Last Dividend Paid	N/A	N/A	N/A	N/A	0.98	N/A	N/A	0.48	8.0	1.67
Shares Owned By Institutions	93.0	98.7	76.65	98.36	76.19	0.19	97.86	99.43	14.23	95.94
Market Capitalization	926.64 M	3.88 B	27.73 M	938.8 M	66.13 M	63.76 M	907.3 M	852.6 M	13.43 B	74.26 B
Price To Earning	130.31	18.23	40.52	28.8	N/A	26.21	14.34	11.39	31.58	43.89
Price To Earnings To Growth	1.56	2.41	0.91	N/A	N/A	2.15	-3.83	1.66	4.51	2.56
Price To Sales	0.82	3.49	0.11	1.57	5.32	N/A	1.31	0.81	0.0448	8.11
Net Income	2.13 M	209.34 M	(2.67 M)	48.16 M	7.34 M	(4.36 M)	41.95 M	2.42 M	55.68 B	2.34 B
Earnings Per Share	0.37	4.1	0.85	2.34	0.9	-0.33	-1.98	0.43	0.78	5.32
Shares Owned By Insiders	7.0	1.3	12.02	1.64	0.43	88.81	2.14	0.57	N/A	0.2
Revenue	1.1 B	1.13 B	316.61 M	566.77 M	11.72 M	N/A	674.98 M	1.02 B	279.16 B	8.54 B
Working Capital	241.31 M	258 M	77.67 M	79.69 M	N/A	7.92 M	412.61 M	396.85 M	152.01 B	4.45 B
Cash And Equivalents	5.4 M	58.49 M	36.56 M	122.72 M	60.62 M	59.41 K	316.39 M	98.67 M	2.93 B	3.58 B
Cash Per Share	0.18	0.72	2.75	3.6	9.75	0.01	6.9	2.44	208.58	5.88
Gross Profit	209.66 M	627.87 M	221.67 M	345.74 M	5.38 M	N/A	393.23 M	298.24 M	113.84 B	5.63 B
Day Typical Price	30.99	78.65	2.11	29.15	12.83	4.93	19.72	21.26	15.9	164.88
Accumulation Distribution	6.0E-4	0.0242	0.2	0.022	0.0062	0.0531	0.0284	0.044	0.0143	0.0181
Market Facilitation Index	0.02	1.93	0.47	0.65	0.08	0.27	0.57	0.96	0.23	3.01
Daily Balance Of Power	N/A	(0.40)	0.0426	(0.58)	(1.00)	(0.11)	(0.28)	(0.66)	1.26087	(0.31)
Period Momentum Indicator	N/A	(0.78)	0.02	(0.38)	(0.08)	(0.03)	(0.16)	(0.63)	0.29	(0.92)
Rate Of Daily Change	1.0	0.99	1.01	0.99	0.99	0.99	0.99	0.97	1.02	0.99
Day Median Price	30.99	78.75	2.17	29.17	12.84	4.95	19.76	21.36	15.93	165.03
Price Action Indicator	(0.01)	(0.68)	(0.16)	(0.24)	(0.08)	(0.06)	(0.19)	(0.62)	0.08	(0.89)
Coefficient Of Variation	845.85	723.94	(567.97)	(665.88)	695.12	6900.45	512.54	(5,368)	23978.92	(606.11)
Mean Deviation	1.51	0.8803	3.94	1.89	1.02	5.73	2.07	1.66	1.07	1.02
Jensen Alpha	0.6952	0.1459	(1.21)	(0.36)	0.2067	0.1024	0.5543	(0.06)	(0.01)	(0.23)
Total Risk Alpha	0.5256	0.12	(1.38)	(0.43)	0.1644	(0.12)	0.4743	(0.11)	(0.04)	(0.26)
Sortino Ratio	0.9463	0.1046	N/A	N/A	0.1677	0.0151	0.2299	N/A	(0.02)	N/A
Downside Variance	0.4988	1.56	N/A	N/A	1.2	37.0	5.37	N/A	1.82	N/A
Standard Deviation	5.93	1.18	6.74	2.34	1.5	8.55	2.9	2.19	1.4	1.32
Kurtosis	64.69	0.9328	16.35	0.2998	4.38	4.46	7.17	1.2	1.41	0.4663
Potential Upside	0.6098	1.72	9.24	2.86	3.36	19.02	4.58	3.42	1.9	1.74
Treynor Ratio	(3.32)	0.4891	(2.82)	13.55	(8.70)	0.2194	22.11	(0.24)	(0.03)	(2.71)
Maximum Drawdown	48.08	5.83	53.71	12.29	8.15	43.32	17.68	12.19	6.89	5.7
Variance	35.11	1.39	45.47	5.48	2.26	73.07	8.38	4.78	1.97	1.73
Market Risk Adjusted Performance	(3.31)	0.4991	(2.81)	13.56	(8.69)	0.2294	22.12	(0.23)	(0.02)	(2.70)
Risk Adjusted Performance	0.1029	0.1134	(0.13)	(0.11)	0.1194	0.0206	0.1628	(0.01)	0.0076	(0.13)
Skewness	8.0	0.1544	(2.65)	(0.47)	1.38	1.76	1.49	0.5199	0.2809	(0.66)
Semi Deviation	0.0	1.08	N/A	N/A	0.7999	5.99	1.92	N/A	1.29	N/A
Information Ratio	0.1128	0.1108	(0.18)	(0.16)	0.1224	0.0107	0.184	(0.03)	(0.02)	(0.19)
Value At Risk	(1.32)	(1.89)	(8.24)	(4.47)	(1.54)	(10.93)	(3.23)	(3.00)	(1.95)	(2.80)
Expected Short fall	(1.69)	(0.88)	N/A	N/A	(1.39)	(7.13)	(2.36)	N/A	(1.18)	N/A
Downside Deviation	0.7063	1.25	N/A	N/A	1.1	6.08	2.32	N/A	1.35	N/A
Semi Variance	(0.49)	1.17	N/A	N/A	0.6399	35.9	3.7	N/A	1.66	N/A

PetIQ Competition Performance Charts

Five steps to successful analysis of PetIQ Competition

PetIQ's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by PetIQ Inc in relation to its competition. PetIQ's competition analysis typically involves several steps, including:

Identifying the key players in the market: This involves identifying the major competitors of PetIQ in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact PetIQ's competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to PetIQ Inc, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your PetIQ position

In addition to having PetIQ in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Long Short Funds Thematic Idea Now

Long Short Funds

Funds or Etfs that are designed to hedge away market risk by investing in combination of bonds, stocks, derivative instruments as well as short positions to maximize returns irrespective of market conditions. The Long Short Funds theme has 42 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Long Short Funds Theme or any other thematic opportunities.

View All Next

Launch

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Consideration for investing in PetIQ Stock

If you are still planning to invest in PetIQ Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PetIQ's history and understand the potential risks before investing.

	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Bonds Directory Find actively traded corporate debentures issued by US companies
	Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators
	Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
	Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account
	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios.
	Commodity Channel Use Commodity Channel Index to analyze current equity momentum

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC